ImmPACT-Bio Competitors and Similar CompaniesClear all
ImmPACT-Bio's competitors and similar companies include Gossamer Bio and Zymeworks.
 ImmPACT-Bio ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy. |  Gossamer Bio Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. |  Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. | |
Founding Date | Founding Date 2017 | Founding Date 2015 | Founding Date 2003 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Camarillo, US HQ Rishon Le Tsiyon, IL | Locations San Diego, US HQ Dublin 2, IE | Locations Vancouver, CA HQ Seattle, US |
Employees | Employees 845% decrease | Employees 11820% increase | Employees 45519% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 208 m | Valuation ($) 973.3 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $48.5m (FY, 2025) | Revenue (est.) $106m (FY, 2025) |
Net income | Net income N/A | Net income ($170.4m) (FY, 2025) | Net income ($81.1m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 18m | Total funding raised $ 480m | Total funding raised $ 125.9m |
For sources of this data, please see the company profile
View Company Profiles
Gossamer Bio
HQ
San Diego, US
Employees
118↑ 20% increase
Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations.
View companyZymeworks
HQ
Vancouver, CA
Employees
455↑ 19% increase
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
View company